|
Volumn 16, Issue 2, 2002, Pages 117-120
|
Pancreatic cancer: Who benefits from curative resection?
a a a |
Author keywords
Pancreatic cancer; Surgical resection
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CELL INFILTRATION;
CONTROLLED STUDY;
DIARRHEA;
DISEASE SEVERITY;
HISTOPATHOLOGY;
HUMAN;
INOPERABLE CANCER;
LYMPH NODE;
LYMPHOID TISSUE;
MESENTERIC ARTERY;
MINIMAL RESIDUAL DISEASE;
MOLECULAR BIOLOGY;
NERVE PLEXUS;
PANCREAS CANCER;
PANCREAS RESECTION;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
PROGNOSIS;
RETROPERITONEUM;
SURGICAL TECHNIQUE;
SURVIVAL TIME;
|
EID: 0036105889
PISSN: 08357900
EISSN: None
Source Type: Journal
DOI: 10.1155/2002/174320 Document Type: Article |
Times cited : (26)
|
References (17)
|